Privium Fund Management’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-163,030	Closed	-$13K	–	269
2022 Q2	$13K	Buy	+163,030	New	+$13K	﹤0.01%	154
2022 Q1	–	Sell	-163,030	Closed	-$42K	–	304
2021 Q4	$42K	Buy	+163,030	New	+$42K	0.01%	147